Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Suitability of Tience® for Treating Acne Scars
Sponsor: Linio Biotech Oy
Summary
This is an open-label, single-center, split-face, pseudo-randomized clinical trial designed to evaluate the efficacy and safety of a human-derived, cell-free adipose tissue derivative (Tience® ), for treating moderate to severe acne scars. Participants will receive three treatment sessions over a three-month period: on Day 0, Day 30, and Day 90. Treatment will be administered via injections to acne-scarred areas on one side of the face. The untreated side will be treated after the follow-up period. Outcomes will be evaluated over a twelve-month period using investigator clinical assessments, patient self-evaluation and VISIA skin analysis system to monitor changes in scar severity and overall skin quality.
Official title: The Suitability of Tience® for the Treatment of Acne Scars
Key Details
Gender
All
Age Range
18 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2025-05-01
Completion Date
2026-12-31
Last Updated
2026-01-28
Healthy Volunteers
No
Conditions
Interventions
Intradermal injections
Three treatment sessions involving intradermal injections of the Tience cell-free allogeneic adipose tissue product administered to one side of the face.
Locations (1)
Aava Kamppi Medical Centre
Helsinki, Finland